BENKOWITZ MICHAEL (PRESIDENT AND COO) sold 7.88K shares of UNITED THERAPEUTICS CORP on the open market
Open‑market sale worth $3.84M. Review remaining holdings and any 10b5‑1 plan disclosures.
Common Stock
Shares
+7.88K
Price / share
$146.03
Trade value
$1.15M
% of position
Common Stock
Shares
−376.00
Price / share
$480.68
Trade value
$180.74K
% of position
Common Stock
Shares
−891.00
Price / share
$481.86
Trade value
$429.34K
% of position
Common Stock
Shares
−471.00
Price / share
$482.72
Trade value
$227.36K
% of position
Common Stock
Shares
−375.00
Price / share
$483.80
Trade value
$181.43K
% of position
Common Stock
Shares
−629.00
Price / share
$484.99
Trade value
$305.06K
% of position
Common Stock
Shares
−899.00
Price / share
$486.05
Trade value
$436.96K
% of position
Common Stock
Shares
−461.00
Price / share
$487.40
Trade value
$224.69K
% of position
Common Stock
Shares
−641.00
Price / share
$488.38
Trade value
$313.05K
% of position
Common Stock
Shares
−364.00
Price / share
$489.49
Trade value
$178.17K
% of position
Common Stock
Shares
−893.00
Price / share
$490.11
Trade value
$437.67K
% of position
Common Stock
Shares
−647.00
Price / share
$491.35
Trade value
$317.90K
% of position
Common Stock
Shares
−598.00
Price / share
$492.44
Trade value
$294.48K
% of position
Common Stock
Shares
−201.00
Price / share
$493.47
Trade value
$99.19K
% of position
Common Stock
Shares
−429.00
Price / share
$494.27
Trade value
$212.04K
% of position
Net shares
+0.00
Net value
-$2.69M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 1/5/2026 | M · Option Exercise | +7.88K | $146.03 | $1.15M | New position | 0.00 | 7.88K |
| Common Stock Indirect | 1/5/2026 | S · Sale | −376.00 | $480.68 | $180.74K | 4.8% | 7.88K | 7.50K |
| Common Stock Indirect | 1/5/2026 | S · Sale | −891.00 | $481.86 | $429.34K | 11.9% | 7.50K | 6.61K |
| Common Stock Indirect | 1/5/2026 | S · Sale | −471.00 | $482.72 | $227.36K | 7.1% | 6.61K | 6.14K |
| Common Stock Indirect | 1/5/2026 | S · Sale | −375.00 | $483.80 | $181.43K | 6.1% | 6.14K | 5.76K |
| Common Stock Indirect | 1/5/2026 | S · Sale | −629.00 | $484.99 | $305.06K | 10.9% | 5.76K | 5.13K |
| Common Stock Indirect | 1/5/2026 | S · Sale | −899.00 | $486.05 | $436.96K | 17.5% | 5.13K | 4.23K |
| Common Stock Indirect | 1/5/2026 | S · Sale | −461.00 | $487.40 | $224.69K | 10.9% | 4.23K | 3.77K |
| Common Stock Indirect | 1/5/2026 | S · Sale | −641.00 | $488.38 | $313.05K | 17.0% | 3.77K | 3.13K |
| Common Stock Indirect | 1/5/2026 | S · Sale | −364.00 | $489.49 | $178.17K | 11.6% | 3.13K | 2.77K |
| Common Stock Indirect | 1/5/2026 | S · Sale | −893.00 | $490.11 | $437.67K | 32.3% | 2.77K | 1.88K |
| Common Stock Indirect | 1/5/2026 | S · Sale | −647.00 | $491.35 | $317.90K | 34.5% | 1.88K | 1.23K |
| Common Stock Indirect | 1/5/2026 | S · Sale | −598.00 | $492.44 | $294.48K | 48.7% | 1.23K | 630.00 |
| Common Stock Indirect | 1/5/2026 | S · Sale | −201.00 | $493.47 | $99.19K | 31.9% | 630.00 | 429.00 |
| Common Stock Indirect | 1/5/2026 | S · Sale | −429.00 | $494.27 | $212.04K | New position | 429.00 | 0.00 |
| Total | +0.00 | -$2.69M | ||||||
Stock Options
Common Stock
7.88K shares
Shares
−7.88K
Strike price
146.03
Held after
52.31K
Exercisable
—
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Options Indirect | Common Stock7.88K shares | 1/5/2026 | M · Option Exercise | −7.88K | 146.03 | — | 52.31K |
Common Stock
Direct| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 2.65K | Direct |
| Total | 2.65K | 2.65K direct |